Strides Pharma Science Limited (NSE:STAR)
1,085.00
-35.00 (-3.13%)
Oct 1, 2026, 3:29 PM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 99.99 billion as of October 1, 2026. Its market cap has increased by 32.20% in one year.
Market Cap
99.99B
Enterprise Value
115.94B
Revenue
50.04B
Ranking
n/a
PE Ratio
16.30
Stock Price
1,085.00
ChartMarket Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 99.99B, an increase of 1,234.26%. That is a compound annual growth rate of 10.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 99.99B | 20.49% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cohance Lifesciences | 175.18B |
| Alembic Pharmaceuticals | 169.34B |
| Alivus Life Sciences | 166.53B |
| Eris Lifesciences | 165.36B |
| NATCO Pharma | 151.01B |
| Sudeep Pharma | 135.00B |
| Akums Drugs and Pharmaceuticals | 125.47B |
| Aarti Pharmalabs | 88.21B |